Clinical Impact of Rapid Reduction of Low-Density Lipoprotein Cholesterol Level on Long-Term Outcome of Acute Myocardial Infarction in the Statin Era: Subanalysis of the ALPS-AMI Study

The optimal period to achieve target percent reduction of low-density lipoprotein cholesterol (LDL-C) level for secondary prevention of acute myocardial infarction (AMI) is not well established. The Assessment of Lipophilic vs. Hydrophilic Statin Therapy in AMI (ALPS-AMI) study enrolled 508 patients...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2015-06, Vol.10 (6), p.e0127835-e0127835
Hauptverfasser:	Miura, Takashi, Izawa, Atsushi, Motoki, Hirohiko, Miyashita, Yusuke, Kashima, Yuichiro, Ebisawa, Souichiro, Tomita, Takeshi, Koyama, Jun, Ikeda, Uichi
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Angioplasty, Balloon, Coronary Anticholesteremic Agents - therapeutic use Balloon angioplasty Blood cholesterol Cardiovascular agents Cardiovascular disease Cerebral infarction Cholesterol Cholesterol tests Cholesterol, HDL - blood Cholesterol, LDL - blood Density Diabetes Female Hazards Health risk assessment Heart attack Humans Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use Hypercholesterolemia - blood Hypercholesterolemia - complications Hypercholesterolemia - drug therapy Hypercholesterolemia - mortality Lipophilic Low density lipoprotein Low density lipoproteins Male Middle Aged Mortality Myocardial infarction Myocardial Infarction - blood Myocardial Infarction - etiology Myocardial Infarction - mortality Myocardial Infarction - therapy Patients Proportional Hazards Models Prospective Studies Randomization Reduction Statins Stroke Survival Analysis Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!